Showing results (91-100 of 199) with videos related to
Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group studyG W Sledge, P Hu, G Falkson, et al.American Journal of Clinical Oncology|October 1, 1988
A phase II evaluation of combination chemotherapy plus aminoglutethimide in women with metastatic or recurrent breast carcinoma. An Eastern Cooperative Oncology Group Pilot StudyJ L Grem, G Falkson, R R Love, et al.American Journal of Clinical Oncology|December 1, 1982
PALA in advanced breast cancer. A phase II pilot study by the ECOGS G Taylor, T E Davis, G Falkson, et al.Cancer Clinical Trials|January 1, 1980
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II studyG Falkson, H C Falkson, H E du Plessis, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 26, 1978
Hepatitis B surface antigen and primary liver cancerA Van Den Heever, F J Pretorius, G Falkson, et al.Cancer|December 1, 1983
Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experienceH J Lerner, D A Schoenfeld, A Martin, et al.Oncology|September 10, 1998
Fadrozole versus megestrol acetate: a double-blind randomised trial in advanced breast cancerW R Bezwoda, A Gudgeon, G Falkson, et al.Archives of Pathology & Laboratory Medicine|June 26, 1999
Morphology and other prognostic factors of hepatocellular carcinomaA Chedid, L M Ryan, Y Dayal, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancerG Falkson, D C Tormey, P Carey, et al.Investigational New Drugs|December 1, 1987
Mitoxantrone in the treatment of acute leukemiaD A Vorobiof, G Falkson, M A Coccia-Portugal, et al.Pageof 20